A global specialist in AI-driven precision medicine, built on 20+ years of research. Its proprietary DINA (Deep Integrated Network Analysis) framework powers two platforms: Mavatar Discovery, accelerating disease and drug research, and Mavatar Precision, delivering personalized treatment recommendations. By creating digital twins of patients and diseases, Mavatar enables data-driven decisions that improve outcomes, optimize trials, and reduce waste. Headquartered in Stockholm, the company is shaping the future of personalized, scalable healthcare.
